Cargando…

Retraction Note to: Differential modulatory effects of GSK-3b and HDM2 on sorafenib-induced AIF nuclear translocation (programmed necrosis) in melanoma

Detalles Bibliográficos
Autores principales: Liu, Qingjun, Mier, James W., Panka, David J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8204411/
https://www.ncbi.nlm.nih.gov/pubmed/34130704
http://dx.doi.org/10.1186/s12943-021-01378-8
_version_ 1783708334591836160
author Liu, Qingjun
Mier, James W.
Panka, David J.
author_facet Liu, Qingjun
Mier, James W.
Panka, David J.
author_sort Liu, Qingjun
collection PubMed
description
format Online
Article
Text
id pubmed-8204411
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-82044112021-06-16 Retraction Note to: Differential modulatory effects of GSK-3b and HDM2 on sorafenib-induced AIF nuclear translocation (programmed necrosis) in melanoma Liu, Qingjun Mier, James W. Panka, David J. Mol Cancer Retraction Note BioMed Central 2021-06-15 /pmc/articles/PMC8204411/ /pubmed/34130704 http://dx.doi.org/10.1186/s12943-021-01378-8 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Retraction Note
Liu, Qingjun
Mier, James W.
Panka, David J.
Retraction Note to: Differential modulatory effects of GSK-3b and HDM2 on sorafenib-induced AIF nuclear translocation (programmed necrosis) in melanoma
title Retraction Note to: Differential modulatory effects of GSK-3b and HDM2 on sorafenib-induced AIF nuclear translocation (programmed necrosis) in melanoma
title_full Retraction Note to: Differential modulatory effects of GSK-3b and HDM2 on sorafenib-induced AIF nuclear translocation (programmed necrosis) in melanoma
title_fullStr Retraction Note to: Differential modulatory effects of GSK-3b and HDM2 on sorafenib-induced AIF nuclear translocation (programmed necrosis) in melanoma
title_full_unstemmed Retraction Note to: Differential modulatory effects of GSK-3b and HDM2 on sorafenib-induced AIF nuclear translocation (programmed necrosis) in melanoma
title_short Retraction Note to: Differential modulatory effects of GSK-3b and HDM2 on sorafenib-induced AIF nuclear translocation (programmed necrosis) in melanoma
title_sort retraction note to: differential modulatory effects of gsk-3b and hdm2 on sorafenib-induced aif nuclear translocation (programmed necrosis) in melanoma
topic Retraction Note
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8204411/
https://www.ncbi.nlm.nih.gov/pubmed/34130704
http://dx.doi.org/10.1186/s12943-021-01378-8
work_keys_str_mv AT liuqingjun retractionnotetodifferentialmodulatoryeffectsofgsk3bandhdm2onsorafenibinducedaifnucleartranslocationprogrammednecrosisinmelanoma
AT mierjamesw retractionnotetodifferentialmodulatoryeffectsofgsk3bandhdm2onsorafenibinducedaifnucleartranslocationprogrammednecrosisinmelanoma
AT pankadavidj retractionnotetodifferentialmodulatoryeffectsofgsk3bandhdm2onsorafenibinducedaifnucleartranslocationprogrammednecrosisinmelanoma